Previous | Next
732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792 of 999
have to make interferon. But I think they aren't going to decide
that until some time in the next month.
What's an inducer?
Well, it's to stimulate the body to make interferon. But
if the body's interferon supplies are deficient, it may be that
the inducer won't work, and so, it's -- it seems to me that perhaps
it might be wiser to make the interferon.
But this is a step that's worth investigating.
Well, they're doing it. I think I probably told you that
a year ago last June 15th, Mrs. Blair, my nephew, Jim Fordyce,
and Dr. Jordan Gutterman went to see Dr. Burns and Dr. Peska at
Hoffman La Roche.
No. That was later. I mean, the Stockholm visit was
earlier. In New Jersey, and urged Dr. Burns, who is the chief
of research for Hoffman La Roche in this country, to get busy
and make interferon. Jordan offered to give him white cells on
which to base a purification of the material, in this year. But
they're still to clone and make it on a commercial scale.
They're going to have pure material which he hopes
to test in the next two months. If the present material is only
.1 of 1 percent pure -- and when you think that that gives a response
in certain kinds of cancers and in viruses, what will it do if
you have pure material?
© 2006 Columbia University
Libraries | Oral History
Research Office | Rights and
Permissions | Help